Neos Therapeutics (NEOS) Misses Q1 EPS by 7c, Slight Miss on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Neos Therapeutics (NEOS) Misses Q1 EPS by 7c, Slight Miss on Revenues

Neos Therapeutics Reports First Quarter 2020 Financial Results

May 11, 2020 4:01 PM EDT

Company announces reduction in force to streamline costs and accelerate the path to profitability, particularly in light of the business impact from the COVID-19 pandemic

Company to host conference call today at 5:00 p.m. EDT

DALLAS and FORT WORTH, Texas, May 11, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today reported financial results for the first quarter ended March 31, 2020 and announced that it is reducing its cost structure by decreasing its workforce... More